This proved to be particularly true for a subset of tumor-infiltrating Vδ2− cells identified in our analysis, which we designated PTT+ owing to their co-expression of established markers of αβ T-cell exhaustion, PD-1, TIGIT and TIM-3. The gene discussed is PDCD1; the disease is neoplasm.